Your journey begins with a detailed consultation and biomarker screening. We review your health history, imaging, and lab results to ensure there are no contraindications to regenerative injection therapy. These biomarkers also help us identify underlying contributors to inflammation, cartilage breakdown, or impaired healing.

If any values fall outside optimal range, we may recommend a 2–4 week preparatory phase that can include IV nutrient therapy, anti-inflammatory support, or targeted supplements to help balance your system and create the most favorable environment for regeneration.

Your first procedure typically involves A2M therapy, a powerful biologic approach for osteoarthritis. Alpha-2-Macroglobulin (A2M) is a naturally occurring protein in the blood that acts as a protease inhibitor—it binds and neutralizes destructive enzymes such as MMPs (matrix metalloproteinases) and ADAMTS that break down cartilage and collagen.

By blocking these catabolic enzymes, A2M helps:

• Slow the progression of osteoarthritis 
• Reduce inflammation within the joint 
• Protect cartilage from further damage 
• Create a healthier joint environment for future regenerative therapies 

This first phase focuses on protection and stabilization—calming the destructive cycle of inflammation so the tissue can begin to repair itself. The procedure is performed in-office under image guidance and typically requires little to no downtime.

Roughly 30 days after your A2M injection, most patients advance to the regenerative phase, where we introduce concentrated biologic materials—such as platelet-rich plasma (PRP) or tissue-derived regenerative cells—to promote active repair and rebuilding of cartilage, tendons, and surrounding soft tissue.

This phase amplifies the healing environment established by A2M. The regenerative cells release growth factors and signaling molecules that:

• Stimulate new collagen formation 
• Enhance tissue repair and strength 
• Improve joint lubrication and function 
• Support long-term joint preservation and comfort 

This biologic layering approach—stabilize, then rebuild—is what distinguishes the Functional Fusion™ process from one-time or single-modality treatments.

After each injection, mild soreness or stiffness may occur for a few days as your body activates its natural repair response. Most clients return to normal activity within 24 hours.

While some improvement may be felt within 4–6 weeks of the A2M injection, the regenerative phase continues working over several months, helping to restore structure and function in the affected joint.

Your provider will schedule follow-up visits at strategic intervals to monitor your progress, evaluate biomarkers, and determine if additional regenerative applications could further enhance your results.

This structured, science-driven process ensures your therapy is delivered at the right time and in the right biological environment. By first stabilizing inflammation with A2M and then activating regeneration with advanced biologics, we help your joints regain integrity, mobility, and comfort—naturally and intelligently.